Our confocal assay proved that UFL1 interacts with STING under the unstimulated condition which means the combination of UFL1 and STING is constitutive, it may provide a new therapeutic target for inhibiting autoimmune disease triggered by abnormally activated STING. Here, STING1 is linked to autoimmune disease.